JournalsHub
.online
Find My Journal
RO

Ross A. Okimoto

City College of San Francisco US

ORCID iD 0000-0002-4467-8476
75
Publications
16,362
Citations
27
H-Index
33
i10-Index
1.38
2yr Mean Cite
-
Cite/Paper
Data combined from OpenAlex . OA = OpenAlex S2 = Semantic Scholar
Verify on Google Scholar

Publication & Citation Trends

Most Cited Works

Activating Mutations in the Epidermal Growth Factor Receptor Underlying Responsiveness of Non–Small-Cell Lung Cancer to Gefitinib
Thomas J. Lynch, Daphne W. Bell, Raffaella Sordella, Sarada Gurubhagavatula, Ross A. Okimoto +9 more
New England Journal of Medicine 2004
11,468
Irreversible inhibitors of the EGF receptor may circumvent acquired resistance to gefitinib
Eunice L. Kwak, Raffaella Sordella, Daphne W. Bell, Nadia Godin-Heymann, Ross A. Okimoto +12 more
Proceedings of the National Academy of Sciences 2005
951
Epidermal Growth Factor Receptor Mutations and Gene Amplification in Non–Small-Cell Lung Cancer: Molecular Analysis of the IDEAL/INTACT Gefitinib Trials
Daphne W. Bell, Thomas J. Lynch, Sara M. Haserlat, Patricia L. Harris, Ross A. Okimoto +15 more
Journal of Clinical Oncology 2005
607
Inherited susceptibility to lung cancer may be associated with the T790M drug resistance mutation in EGFR
Daphne W. Bell, Ira Gore, Ross A. Okimoto, Nadia Godin-Heymann, Raffaella Sordella +6 more
Nature Genetics 2005
531
Amplification of <i>MET</i> may identify a subset of cancers with extreme sensitivity to the selective tyrosine kinase inhibitor PHA-665752 OA
Gromoslaw A. Smolen, Raffaella Sordella, Beth Muir, Gayatry Mohapatra, Anne Barmettler +8 more
Proceedings of the National Academy of Sciences 2006
483

Publications

75 total

Clinical genomic profiling in the management of patients with soft tissue and bone sarcoma PDF

Mrinal M. Gounder, Narasimhan P. Agaram, Sally E. Trabucco, Victoria Robinson, Richard Ferraro et al. - Nature Communications, 2022
Cited by 183 OpenAlex

Single-cell lineages reveal the rates, routes, and drivers of metastasis in cancer xenografts PDF

Jeffrey J. Quinn, Matthew G. Jones, Ross A. Okimoto, Shigeki Nanjo, Michelle M. Chan et al. - Science, 2021
Cited by 309 OpenAlex

Nuclear TARBP2 Drives Oncogenic Dysregulation of RNA Splicing and Decay PDF

Lisa Fish, Albertas Navickas, Bruce Culbertson, Yichen Xu, Hoang C.B. Nguyen et al. - Molecular Cell, 2019
Cited by 87 OpenAlex

Inactivation of Capicua drives cancer metastasis

Ross A. Okimoto, Frank Breitenbuecher, Victor Olivas, Wei Wu, Beatrice Gini et al. - Nature Genetics, 2016
Cited by 166 OpenAlex

Preclinical efficacy of a RAF inhibitor that evades paradoxical MAPK pathway activation in protein kinase <i>BRAF</i> -mutant lung cancer PDF

Ross A. Okimoto, Luping Lin, Victor Olivas, Elton Chan, Evan Markegard et al. - Proceedings of the National Academy of Sciences, 2016
Cited by 77 OpenAlex

RAS-MAPK dependence underlies a rational polytherapy strategy in EML4-ALK–positive lung cancer PDF

Gorjan Hrustanovic, Victor Olivas, Evangelos Pazarentzos, Asmin Tulpule, Saurabh Asthana et al. - Nature Medicine, 2015
Cited by 276 OpenAlex

Mutations in the neutral sphingomyelinase gene SMPD3 implicate the ceramide pathway in human leukemias PDF

Woo‐Jae Kim, Ross A. Okimoto, Louise E. Purton, Meagan Goodwin, Sara M. Haserlat et al. - Blood, 2008
Cited by 87 OpenAlex

Amplification of <i>MET</i> may identify a subset of cancers with extreme sensitivity to the selective tyrosine kinase inhibitor PHA-665752 PDF

Gromoslaw A. Smolen, Raffaella Sordella, Beth Muir, Gayatry Mohapatra, Anne Barmettler et al. - Proceedings of the National Academy of Sciences, 2006
Cited by 483 OpenAlex

Epidermal Growth Factor Receptor Kinase Domain Mutations in Esophageal and Pancreatic Adenocarcinomas PDF

Eunice L. Kwak, Janusz Jankowski, Sarah P. Thayer, Gregory Y. Lauwers, Brian W. Brannigan et al. - Clinical Cancer Research, 2006
Cited by 158 OpenAlex

Irreversible inhibitors of the EGF receptor may circumvent acquired resistance to gefitinib

Eunice L. Kwak, Raffaella Sordella, Daphne W. Bell, Nadia Godin-Heymann, Ross A. Okimoto et al. - Proceedings of the National Academy of Sciences, 2005
Cited by 951 OpenAlex

Research Topics

Lung Cancer Treatments and Mutations (15) Cancer Genomics and Diagnostics (15) Sarcoma Diagnosis and Treatment (10) RNA modifications and cancer (8) Protein Degradation and Inhibitors (8)

Frequent Co-Authors

DA
Daphne W. Bell
8 joint publications
DA
Daniel A. Haber
8 joint publications
BR
Brian W. Brannigan
6 joint publications
PA
Patricia L. Harris
5 joint publications
SA
Sara M. Haserlat
5 joint publications
RA
Raffaella Sordella
4 joint publications

Affiliations

Creighton University
US 2005 - 2003
Tufts Medical Center
US 2011 - 2011
Harvard University
US 2023 - 2004
City College of San Francisco
US 2026 - 2026
University of California, San Francisco
US 2026 - 2014

External Profiles

OpenAlex Profile Search Semantic Scholar ORCID Profile Google Scholar

Share Profile

Back to Researchers
Comparison Shortlist
0 journals
Est. APC Budget: $0
Compare Now